Results 171 to 180 of about 1,433 (211)
Some of the next articles are maybe not open access.

ANTITHROMBIN IN INFANCY AND CHILDHOOD

Acta Paediatrica, 1975
ABSTRACT: Teger‐Nilsson, A‐C. (Department of Clinical Chemistry, Department of Pediatrics, and Department of Blood Coagulation Research, Karolinska sjukhuset, Stockholm). Antithrombin in infancy and childhood. Acta Pediatr Scand, 64:624, 1975.–Anti‐thrombin III was measured immunologically, and antithrombin activity was measured with aid of a new ...
A, Catrine, T, Nilsson
openaire   +2 more sources

Distinction of two pathologic antithrombin III molecules: Antithrombin III ‘Aalborg’ and antithrombin III ‘Budapest’

Thrombosis Research, 1982
Plasma from two different thrombophilic families with functional inherited antithrombin III deficiency, i.e., with low antithrombin III activity but normal immunoreactive antithrombin III concentration, were investigated simultaneously in the same laboratory.
P J, Sørensen   +5 more
openaire   +2 more sources

Neonatal antithrombin III

British Journal of Haematology, 1984
SummaryAntithrombin III (AT‐III) heparin cofactor activity and its antigen levels have been determined in 106 plasma samples from 42 term and preterm neonates. In contrast to healthy adult controls, a reduced activity/antigen (act/ag) ratio (ranging from 0‐26 to 0‐86) was observed in 90% of the samples and was independent of the state of health of the ...
Peters, M.   +5 more
openaire   +3 more sources

Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency

Thrombosis and Haemostasis, 2009
SummaryAntithrombin (AT) functions as a potent natural anticoagulant and serine protease inhibitor that inactivates many enzymes in the coagulation cascade. Antithrombin also possesses anti-inflammatory properties, many of which are mediated by its actions as an anticoagulant.
openaire   +2 more sources

Heparin and Antithrombin 3

Archives of Surgery, 1979
To the Editor .—The white clot syndrome recently reported by Towne et al 1 is disturbing. The complications of therapy with heparin are a problem not only for physician and patient, but for the clinical pharmacist, who is often called on to explain them.
openaire   +2 more sources

Antithrombin III

International Journal of Biochemistry, 1990
C H, Beresford, M C, Owen
openaire   +2 more sources

Antithrombin III deficiency

Blood Reviews, 1988
A moderate reduction of plasma antithrombin activity is an uncommon but clinically important cause of severe thromboembolic disease. In recent years the molecule responsible for the major part of this activity (antithrombin III) has been extensively characterised and the mode of inheritance of familial deficiencies worked out.
openaire   +2 more sources

Antithrombin

2007
S.J. Enna, David B. Bylund
openaire   +2 more sources

Platelet function and antithrombins in hyperlipoproteinemia type IIa

Thrombosis Research, 1981
L Kordich   +2 more
exaly  

Antithrombin

1997
Ingemar Björk, Steven T. Olson
openaire   +1 more source

Home - About - Disclaimer - Privacy